Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Artificial Intelligence in Diagnostics Market, by Component
1.4.2 Europe Artificial Intelligence in Diagnostics Market, by Diagnosis
1.4.3 Europe Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.5 Porter Five Forces Analysis
Chapter 5. Europe Artificial Intelligence in Diagnostics Market by Component
5.1 Europe Software Market by Country
5.2 Europe Hardware Market by Country
5.3 Europe Services Market by Country
Chapter 6. Europe Artificial Intelligence in Diagnostics Market by Diagnosis
6.1 Europe Neurology Market by Country
6.2 Europe Radiology Market by Country
6.3 Europe Chest & Lung Market by Country
6.4 Europe Oncology Market by Country
6.5 Europe Cardiology Market by Country
6.6 Europe Pathology Market by Country
6.7 Europe Other Diagnosis Market by Country
Chapter 7. Europe Artificial Intelligence in Diagnostics Market by Country
7.1 Germany Artificial Intelligence in Diagnostics Market
7.1.1 Germany Artificial Intelligence in Diagnostics Market by Component
7.1.2 Germany Artificial Intelligence in Diagnostics Market by Diagnosis
7.2 UK Artificial Intelligence in Diagnostics Market
7.2.1 UK Artificial Intelligence in Diagnostics Market by Component
7.2.2 UK Artificial Intelligence in Diagnostics Market by Diagnosis
7.3 France Artificial Intelligence in Diagnostics Market
7.3.1 France Artificial Intelligence in Diagnostics Market by Component
7.3.2 France Artificial Intelligence in Diagnostics Market by Diagnosis
7.4 Russia Artificial Intelligence in Diagnostics Market
7.4.1 Russia Artificial Intelligence in Diagnostics Market by Component
7.4.2 Russia Artificial Intelligence in Diagnostics Market by Diagnosis
7.5 Spain Artificial Intelligence in Diagnostics Market
7.5.1 Spain Artificial Intelligence in Diagnostics Market by Component
7.5.2 Spain Artificial Intelligence in Diagnostics Market by Diagnosis
7.6 Italy Artificial Intelligence in Diagnostics Market
7.6.1 Italy Artificial Intelligence in Diagnostics Market by Component
7.6.2 Italy Artificial Intelligence in Diagnostics Market by Diagnosis
7.7 Rest of Europe Artificial Intelligence in Diagnostics Market
7.7.1 Rest of Europe Artificial Intelligence in Diagnostics Market by Component
7.7.2 Rest of Europe Artificial Intelligence in Diagnostics Market by Diagnosis
Chapter 8. Company Profiles
8.1 Siemens Healthineers AG (Siemens AG)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Zebra Technologies Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.6 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Microsoft Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 IBM Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 DeepScribe Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 AliveCor, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Digital Diagnostics, Inc. (3Derm Systems, Inc.)
8.10.1 Company Overview
Unique Offerings 